About Tepnel
Provider of pharmaceutical testing services supporting drug development and regulatory compliance. It offers regulatory compliant analytics for small and large molecule APIs, IMPs, and finished products. Services include lot and batch release testing, ICH method development and validation, raw material testing per pharmacopoeia standards, and ICH stability testing and storage. The company focuses on pharmaceutical testing in support of drug development with an emphasis on inhalation, oral dosage, parenteral and biologics.
- Headquarter Livingston, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Tepnel
Detailed funding history for Tepnel
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Tepnel
Tepnel has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gen-Probe.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides clinical diagnostics, blood screening, and research products.
|
Locked | Locked | Locked |
Investor details for Tepnel
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tepnel
Investment portfolio details for Tepnel
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tepnel
Detailed financials for Tepnel
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tepnel Comparisons
Peer comparison for Tepnel
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tepnel
Detailed competitors of Tepnel
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tepnel
Complete news archive for Tepnel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tepnel
Tepnel was founded in 1999.
Tepnel is headquartered in Livingston, United Kingdom. It is registered at Livingston, Scotland, United Kingdom.
Provider of pharmaceutical testing services supporting drug development and regulatory compliance. It offers regulatory compliant analytics for small and large molecule APIs, IMPs, and finished products. Services include lot and batch release testing, ICH method development and validation, raw material testing per pharmacopoeia standards, and ICH stability testing and storage. The company focuses on pharmaceutical testing in support of drug development with an emphasis on inhalation, oral dosage, parenteral and biologics.
Tepnel has 1 investor. Key investors include Gen-Probe.